Everolimus-Eluting Coronary Artery Stent
Vietnam·Risk Class TTBYT Loại D·I-Sync - Everolimus Eluting Coronary Stent System·Purple MicroPort Cardiovascular Private Limited·Registered Nov 14, 2024- Analysis ID
- 2403537ĐKLH/BYT-HTTB
- Submission ID
- 000.00.04.G18-230814-0005
- Product Type
- I-Sync - Everolimus Eluting Coronary Stent System
- Manufacturer
- Purple MicroPort Cardiovascular Private Limited
- Manufacturer Country
- INDIA
- Product Owner
- Purple MicroPort Cardiovascular Private Limited
- Authorized Representative
- CÔNG TY TNHH VIMEDICAL
- Intended Use
- The I-Sync everolimus-coated stent system is indicated to improve the coronary lumen diameter in symptomatic patients with coronary artery disease undergoing percutaneous transluminal coronary angioplasty (PTCA) in the setting of new coronary artery disease in the native coronary arteries of eligible patients.
- Registration Date
- Nov 14, 2024
Companies providing products similar to "Everolimus-Eluting Coronary Artery Stent"
Recently registered similar products
Access comprehensive regulatory information for Everolimus-Eluting Coronary Artery Stent in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2403537ĐKLH/BYT-HTTB and manufactured by Purple MicroPort Cardiovascular Private Limited. The authorized representative in Vietnam is CÔNG TY TNHH VIMEDICAL.
This page provides complete technical specifications, regulatory compliance details, 3 companies making similar products including Abbott Medical, Boston Scientific Limited, and 4 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.